Discontinuation report APO-RANITIDINE TABLET 300MG

Last updated on 2018-09-08 History
Report ID 60732
Drug Identification Number 00733067
Brand name APO-RANITIDINE TABLET 300MG
Common or Proper name RANITIDINE
Company Name APOTEX INC
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 BTL
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-08-28
Actual discontinuation date
Remaining supply date 2019-08-28
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-09-08 French Compare
v1 2018-09-08 English Compare